Dossier
inflammatory disease drug
Coverage of inflammatory disease drug in the Nexus archive.
- AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug
AbbVie acquired Apogee for $10.9 billion to gain an inflammatory disease drug. The deal is AbbVie's largest in over five years and reflects increased M&A activity in the pharmaceutical sector.